Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

被引:14
|
作者
Lukka, H. [1 ]
Stephanie, P. [2 ]
Bruner, D. [3 ]
Bahary, J. P. [4 ]
Lawton, C. A. F. [5 ]
Efstathiou, J. A. [6 ]
Kudchadker, R. [7 ]
Ponsky, L. [8 ]
Seaward, S. A. [9 ]
Dayes, I. S. [10 ]
Gopaul, D. D. [11 ]
Michalski, J. M. [12 ]
Delouya, G. [13 ]
Kaplan, I. D. [14 ]
Horwitz, E. M. [15 ]
Roach, M., III [16 ]
Pinover, W. H. [17 ]
Beyer, D. C. [18 ]
Sandler, H. M. [19 ]
Kachnic, L. A. [20 ]
机构
[1] Juravinski Canc Ctr Hamilton Hlth Sci, Hamilton, ON, Canada
[2] NRG Oncol Stat & Data Management Ctr, Philadelphia, PA USA
[3] Emory Univ, Atlanta, GA 30322 USA
[4] Hop Notre Dame CHUM, Montreal, PQ, Canada
[5] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[6] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02115 USA
[7] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[8] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA
[9] Kaiser Permanente No Calif, Santa Clara, CA USA
[10] McMaster Univ, Hamilton, ON, Canada
[11] Grand River Reg Canc Ctr, Kitchener, ON, Canada
[12] Washington Univ, Sch Med, St Louis, MO USA
[13] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[14] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[15] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[16] Univ Calif San Francisco, San Francisco, CA 94143 USA
[17] Abington Mem Hosp, Abington, PA 19001 USA
[18] Fdn Canc Res & Educ, Phoenix, AZ USA
[19] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[20] Boston Med Ctr, Boston, MA USA
关键词
D O I
10.1016/j.ijrobp.2015.10.046
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LBA 3
引用
收藏
页码:2 / 2
页数:1
相关论文
共 50 条
  • [1] Patient Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase II Study Evaluating 2 Ultrahypofractionated Regimens (UHR) for Prostate Cancer (CaP)
    Lukka, H.
    Deshmukh, S.
    Bruner, D. W.
    Bahary, J. P.
    Lawton, C. A. F.
    Efstathiou, J. A.
    Kudchadker, R.
    Ponsky, L.
    Seaward, S. A.
    Dayes, I.
    Gopaul, D. D.
    Michalski, J. M.
    Delouya, G.
    Kaplan, I. D.
    Horwitz, E. M.
    Roach, M., III
    Beyer, D. C.
    Sandler, H. M.
    Kachnic, L. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S119 - S120
  • [2] Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
    Lukka, Himanshu R.
    Pugh, Stephanie L.
    Bruner, Deborah W.
    Bahary, Jean-Paul
    Lawton, Colleen A. F.
    Efstathiou, Jason A.
    Kudchadker, Rajat J.
    Ponsky, Lee E.
    Seaward, Samantha A.
    Dayes, Ian S.
    Gopaul, Darindra D.
    Michalski, Jeff M.
    Delouya, Guila
    Kaplan, Irving D.
    Horwitz, Eric M.
    Roach, Mack, III
    Pinover, Wayne H.
    Beyer, David C.
    Amanie, John O.
    Sandler, Howard M.
    Kachnic, Lisa A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (02): : 287 - 295
  • [3] Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
    Lukka, Himanshu R.
    Deshmukh, Snehal
    Bruner, Deborah W.
    Bahary, Jean-Paul
    Lawton, Colleen A. F.
    Efstathiou, Jason A.
    Kudchadker, Rajat J.
    Ponsky, Lee E.
    Seaward, Samantha A.
    Dayes, Ian S.
    Gopaul, Darindra D.
    Michalski, Jeff M.
    Delouya, Guila
    Kaplan, Irving D.
    Horwitz, Eric M.
    Roach, Mack
    Feng, Felix Y.
    Pugh, Stephanie L.
    Sandler, Howard M.
    Kachnic, Lisa A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 116 (04): : 770 - 778
  • [4] Patient reported outcomes in NRG Oncology/RTOG 0938, evaluating two ultrahypofractionated regimens (UHR) for prostate cancer (CaP)
    Lukka, Himanshu
    Pugh, Stephanie L.
    Bruner, Deborah
    Bahary, Jean-Paul
    Lawton, Colleen Anne
    Efstathiou, Jason A.
    Kudchadker, Rajat
    Ponsky, Lee Evan
    Seaward, Samantha A.
    Dayes, Ian S.
    Gopaul, Darindra
    Michalski, Jeff M.
    Delouya, Guila
    Kaplan, Irving D.
    Horwitz, Eric M.
    Roach, Mack
    Pinover, Wayne
    Beyer, David
    Sandler, Howard M.
    Kachnic, Lisa A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [5] Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415
    Bai, Jinbing
    Pugh, Stephanie L.
    Eldridge, Ronald
    Yeager, Katherine A.
    Zhang, Qi
    Lee, W. Robert
    Shah, Amit B.
    Dayes, Ian S.
    D'Souza, David P.
    Michalski, Jeff M.
    Efstathiou, Jason A.
    Longo, John M.
    Pisansky, Thomas M.
    Maier, Jordan M.
    Faria, Sergio L.
    Desai, Anand B.
    Seaward, Samantha A.
    Sandler, Howard M.
    Cooley, Mary E.
    Bruner, Deborah W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 116 (01): : 39 - 49
  • [6] Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery
    Kachnic, Lisa A.
    Winter, Kathryn
    Suntharalingam, Mohan
    Ilson, David
    Konski, Andre
    Lloyd, Shane
    Mcavoy, Sarah A.
    Lad, Thomas
    Olowokure, Olugbenga Gbenga
    Samson, Pamela
    Gore, Elizabeth M.
    Meyer, Joshua E.
    Videtic, Gregory M. M.
    Clump, David A.
    Raben, Adam
    Kayaleh, Omar
    Barker Jr, Jerry
    Haddock, Michael G.
    Hopkins, Judith O.
    Bruner, Deborah W.
    QUALITY OF LIFE RESEARCH, 2024, 33 (10) : 2833 - 2844
  • [7] Patient-Reported Outcomes (PROs) in NRG Oncology/RTOG 0436: A Phase 3 Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Esophageal Cancer Treated Without Surgery
    Kachnic, L. A.
    Moughan, J.
    Suntharalingam, M.
    Ilson, D. H.
    Konski, A. A.
    Burrows, W.
    Anker, C.
    Bar Ad, V.
    Thakrar, H. V.
    Hayes, J. P.
    Gore, E. M.
    Kavadi, V. S.
    Komaki, R. U.
    Raben, A.
    Giguere, J. K.
    Pollock, J.
    Greenberger, J. S.
    Videtic, G. M.
    Roof, K. S.
    Bruner, D. Watkins
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S31 - S31
  • [8] Patient-Reported Outcomes (PROs) in NRG Oncology RTOG 1010: Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2 Overexpressing (HER2+) Esophageal Adenocarcinoma (EAC)
    Kachnic, L. A.
    Moughan, J.
    Hong, T. S.
    Haddock, M. G.
    Tahir, N.
    Yoon, H. H.
    Pardo, D. A. Diaz
    Anderson, C. M.
    Seaward, S. A.
    Lominska, C.
    O'brien, P.
    Katz, A. W.
    Salo, J.
    Christie, A. D., Jr.
    Dorth, J. A.
    Aljumaily, R.
    Gore, E. M.
    Safyan, H. P.
    Movsas, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S14 - S14
  • [9] Rurality and neighborhood socioeconomic deprivation associated with patient-reported outcomes andsurvivalin men with prostate cancer in NRG RTOG 0415.
    Bai, Jinbing
    Pugh, Stephanie L.
    Eldridge, Ronald
    Yeager, Katherine
    Zhang, Qi
    Lee, W. Robert
    Shah, Amit B.
    Dayes, Ian S.
    D'Souza, David P.
    Michalski, Jeff M.
    Efstathiou, Jason A.
    Longo, John M.
    Pisansky, Thomas M.
    Maier, Jordan M.
    Faria, Sergio L.
    Desai, Anand B.
    Seaward, Samantha A.
    Sandler, Howard M.
    Cooley, Mary E.
    Bruner, Deborah W.
    CANCER RESEARCH, 2021, 81 (13)
  • [10] NRG Oncology RTOG 0415: A Randomized Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer
    Lee, W. R.
    Dignam, J. J.
    Amin, M.
    Bruner, D.
    Low, D.
    Swanson, G. P.
    Shah, A. B.
    D'Souza, D. P.
    Michalski, J. M.
    Dayes, I. S.
    Seaward, S. A.
    Hall, W. A.
    Nguyen, P. L.
    Pisansky, T. M.
    Faria, S.
    Chen, Y.
    Koontz, B. F.
    Paulus, R.
    Sandler, H. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (01): : 3 - 4